Fundz

NEXGEL

Langhorne, Pennsylvania, United States · Biotechnology, Health Care

Nexgel is a company focused on developing and commercializing innovative hydrogel products. They specialize in regenerative biomaterials and have a range of products in various stages of development. The company aims to enhance patient care with their advanced biomaterial solutions. Nexgel is publicly traded under the ticker symbol NXGL.

You have opened 5 full company profiles today. Create an account to keep reading them. Create an account

Key facts

Headquarters
Langhorne, Pennsylvania, United States
Employees
7
Industries
Biotechnology, Health Care
Status
Public (NXGL)
Website
nexgel.com
LinkedIn
Company page

Recent activity at NEXGEL

  • : SEC 8-K (1.01): On November 10, 2026, NexGel, Inc. entered into Note Amendment and Conversion Agreements with holders of its convertible promissory notes representing approximately $14.125 million. Additionally, the Company engaged in a Securities Purchase Agreement for a private placement of common stock and warrants. These transactions are part of a broader recapitalization plan aimed at a strategic merger with Fountainhead LifeSciences and its affiliates, which is considered a related party transaction due to involvement of the Company's Interim CEO, Brian Kieser. The transactions and proposed merger are contingent upon further board approvals and the completion of specific conditions.
  • : SEC 8-K (7.01): On September 24, 2026, NexGel, Inc. initiated a new shareholder update presentation titled 'Strategic Review & Proposed Platform Reorganization'. This presentation outlines the company’s strategic direction and proposed changes to its platform, which could impact its operational focus and future direction. The filing includes Exhibit 99.1, detailing this strategic initiative, although it has been noted that the information provided is not deemed 'filed' for regulatory purposes, indicating that it serves primarily as a disclosure to inform investors and stakeholders of the company's evolving strategy.
  • : SEC 8-K (5.07): On September 23, 2026, NexGel, Inc. held its 2026 Special Meeting of Stockholders where stockholders voted on three proposals affecting the company's governance. A total of 6,200,043 shares of common stock were represented at the meeting, out of 9,747,663 shares entitled to vote, which constituted a quorum. The proposals discussed were previously detailed in a definitive proxy statement filed on August 24, 2026. This event marks significant engagement from shareholders and may impact future company decisions and direction.

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Employee benefit plans

NEXGEL files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

About NEXGEL: questions and answers

What does NEXGEL do?

Nexgel is a company focused on developing and commercializing innovative hydrogel products. They specialize in regenerative biomaterials and have a range of products in various stages of development. The company aims to enhance patient care with their advanced biomaterial solutions. Nexgel is publicly traded under the ticker symbol NXGL.

Where is NEXGEL headquartered?

NEXGEL is headquartered in Langhorne, Pennsylvania, United States.

How many employees does NEXGEL have?

NEXGEL has about 7 employees.

What is the latest news on NEXGEL?

On Sep 23, 2026, SEC 8-K (1.01): On November 10, 2026, NexGel, Inc. entered into Note Amendment and Conversion Agreements with holders of its convertible promissory notes representing approximately $14.125 million. Additionally, the Company engaged in a Securities Purchase Agreement for a private placement of common

Is NEXGEL a public company?

Yes. NEXGEL is publicly traded under the ticker NXGL.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches NEXGEL across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.